Korro Bio Inc. – Filings and Transcripts

NASDAQ: KRRO
Share price (6/11/26): $10.53
Market cap (6/11/26): $152 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Bermingham Nessan

Knobil Katharine

Formela Jean Francois

News Filter

Shareholder Vote Results

Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Announces Oversubscribed $85 Million Private Placement

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission